Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis

[1] Merikangas KR(2007)Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch Gen Psychiatry 64 543-552

[2] Akiskal HS(2011)Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative Arch Gen Psychiatry 68 241-251

[3] Angst J(2009)Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey Lancet 373 2041-2053

[4] Greenberg PE(2013)Treatment of bipolar disorder Lancet 381 1672-1682

[5] Hirschfeld RM(2013)Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 Bipolar Disord 15 1-44

[6] Petukhova M(2007)Differentiating bipolar disorders from major depressive disorders: treatment implications Ann Clin Psychiatry 19 305-312

[7] Kessler RC(2010)Comorbid anxiety and substance use disorders associated with a lower use of mood stabilizers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients Int J Clin Prac 64 336-344

[8] Merikangas KR(2012)Undiagnosed bipolar disorder in patients treated for major depression in China J Affect Disord 140 181-186

[9] Jin R(2013)Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China Bipolar Disord 15 199-205

[10] He JP(2014)The relationship between neurotrophins and bipolar disorder Expert Rev Neurother 14 51-65

[1] Merikangas KR(2007)Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch Gen Psychiatry 64 543-552

[2] Akiskal HS(2011)Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative Arch Gen Psychiatry 68 241-251

[3] Angst J(2009)Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey Lancet 373 2041-2053

[4] Greenberg PE(2013)Treatment of bipolar disorder Lancet 381 1672-1682

[5] Hirschfeld RM(2013)Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 Bipolar Disord 15 1-44

[6] Petukhova M(2007)Differentiating bipolar disorders from major depressive disorders: treatment implications Ann Clin Psychiatry 19 305-312

[7] Kessler RC(2010)Comorbid anxiety and substance use disorders associated with a lower use of mood stabilizers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients Int J Clin Prac 64 336-344

[8] Merikangas KR(2012)Undiagnosed bipolar disorder in patients treated for major depression in China J Affect Disord 140 181-186

[9] Jin R(2013)Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China Bipolar Disord 15 199-205

[10] He JP(2014)The relationship between neurotrophins and bipolar disorder Expert Rev Neurother 14 51-65